• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对多发性硬化症中基因-基因相互作用的系统分析。

A systematic analysis of gene-gene interaction in multiple sclerosis.

机构信息

CBIO, MINES ParisTech, PSL Research University, 75006, Paris, France.

Translational Sciences, SANOFI R&D, 91385, Chilly-Mazarin, France.

出版信息

BMC Med Genomics. 2022 Apr 30;15(1):100. doi: 10.1186/s12920-022-01247-3.

DOI:10.1186/s12920-022-01247-3
PMID:35501860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9063218/
Abstract

BACKGROUND

For the most part, genome-wide association studies (GWAS) have only partially explained the heritability of complex diseases. One of their limitations is to assume independent contributions of individual variants to the phenotype. Many tools have therefore been developed to investigate the interactions between distant loci, or epistasis. Among them, the recently proposed EpiGWAS models the interactions between a target variant and the rest of the genome. However, applying this approach to studying interactions along all genes of a disease map is not straightforward. Here, we propose a pipeline to that effect, which we illustrate by investigating a multiple sclerosis GWAS dataset from the Wellcome Trust Case Control Consortium 2 through 19 disease maps from the MetaCore pathway database.

RESULTS

For each disease map, we build an epistatic network by connecting the genes that are deemed to interact. These networks tend to be connected, complementary to the disease maps and contain hubs. In addition, we report 4 epistatic gene pairs involving missense variants, and 25 gene pairs with a deleterious epistatic effect mediated by eQTLs. Among these, we highlight the interaction of GLI-1 and SUFU, and of IP10 and NF-[Formula: see text]B, as they both match known biological interactions. The latter pair is particularly promising for therapeutic development, as both genes have known inhibitors.

CONCLUSIONS

Our study showcases the ability of EpiGWAS to uncover biologically interpretable epistatic interactions that are potentially actionable for the development of combination therapy.

摘要

背景

大多数情况下,全基因组关联研究(GWAS)仅部分解释了复杂疾病的遗传率。其局限性之一是假设个体变异对表型的独立贡献。因此,已经开发了许多工具来研究远隔基因座之间的相互作用,或上位性。其中,最近提出的 EpiGWAS 模型可以模拟目标变体与基因组其余部分之间的相互作用。然而,直接将这种方法应用于研究疾病图谱中所有基因的相互作用并不容易。在这里,我们提出了一种实现这一目标的方法,并通过研究来自 Wellcome Trust Case Control Consortium 2 的多发性硬化症 GWAS 数据集以及来自 MetaCore 途径数据库的 19 个疾病图谱来说明。

结果

对于每个疾病图谱,我们通过连接被认为相互作用的基因来构建上位性网络。这些网络往往是相互连接的,与疾病图谱互补,并且包含枢纽。此外,我们报告了涉及错义变异的 4 对上位性基因对,以及涉及 eQTLs 的 25 对具有有害上位性效应的基因对。其中,我们强调了 GLI-1 和 SUFU 以及 IP10 和 NF-[Formula: see text]B 之间的相互作用,因为它们都与已知的生物学相互作用相匹配。后者对治疗开发特别有希望,因为这两个基因都有已知的抑制剂。

结论

我们的研究展示了 EpiGWAS 发现潜在可用于开发联合治疗的生物学可解释上位性相互作用的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/69b7a4165974/12920_2022_1247_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/ea78789c5925/12920_2022_1247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/afd4cac3470d/12920_2022_1247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/e9bbaf8c84de/12920_2022_1247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/ff5c58c7d82d/12920_2022_1247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/69b7a4165974/12920_2022_1247_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/ea78789c5925/12920_2022_1247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/afd4cac3470d/12920_2022_1247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/e9bbaf8c84de/12920_2022_1247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/ff5c58c7d82d/12920_2022_1247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/9063218/69b7a4165974/12920_2022_1247_Fig5_HTML.jpg

相似文献

1
A systematic analysis of gene-gene interaction in multiple sclerosis.对多发性硬化症中基因-基因相互作用的系统分析。
BMC Med Genomics. 2022 Apr 30;15(1):100. doi: 10.1186/s12920-022-01247-3.
2
Gene, pathway and network frameworks to identify epistatic interactions of single nucleotide polymorphisms derived from GWAS data.用于识别源自全基因组关联研究(GWAS)数据的单核苷酸多态性上位性相互作用的基因、通路和网络框架。
BMC Syst Biol. 2012;6 Suppl 3(Suppl 3):S15. doi: 10.1186/1752-0509-6-S3-S15. Epub 2012 Dec 17.
3
Epistatic Gene-Based Interaction Analyses for Glaucoma in eMERGE and NEIGHBOR Consortium.基于上位性基因的青光眼交互作用分析:eMERGE和NEIGHBOR联盟研究
PLoS Genet. 2016 Sep 13;12(9):e1006186. doi: 10.1371/journal.pgen.1006186. eCollection 2016 Sep.
4
A Genome-Wide Association Analysis Reveals Epistatic Cancellation of Additive Genetic Variance for Root Length in Arabidopsis thaliana.全基因组关联分析揭示了拟南芥根长加性遗传变异的上位性消除。
PLoS Genet. 2015 Sep 23;11(9):e1005541. doi: 10.1371/journal.pgen.1005541. eCollection 2015.
5
iLOCi: a SNP interaction prioritization technique for detecting epistasis in genome-wide association studies.iLOCi:一种 SNP 相互作用优先级技术,用于检测全基因组关联研究中的上位性。
BMC Genomics. 2012;13 Suppl 7(Suppl 7):S2. doi: 10.1186/1471-2164-13-S7-S2. Epub 2012 Dec 13.
6
Novel methods for epistasis detection in genome-wide association studies.全基因组关联研究中上位性检测的新方法。
PLoS One. 2020 Nov 30;15(11):e0242927. doi: 10.1371/journal.pone.0242927. eCollection 2020.
7
Prioritizing tests of epistasis through hierarchical representation of genomic redundancies.通过基因组冗余的分层表示对上位性测试进行优先级排序。
Nucleic Acids Res. 2017 Aug 21;45(14):e131. doi: 10.1093/nar/gkx505.
8
Detecting purely epistatic multi-locus interactions by an omnibus permutation test on ensembles of two-locus analyses.通过对两基因座分析集合进行整体置换检验来检测纯上位多基因座相互作用。
BMC Bioinformatics. 2009 Sep 17;10:294. doi: 10.1186/1471-2105-10-294.
9
GWIS--model-free, fast and exhaustive search for epistatic interactions in case-control GWAS.GWIS--无模型、快速且全面搜索病例对照 GWAS 中的上位相互作用。
BMC Genomics. 2013;14 Suppl 3(Suppl 3):S10. doi: 10.1186/1471-2164-14-S3-S10. Epub 2013 May 28.
10
Detecting epistasis with the marginal epistasis test in genetic mapping studies of quantitative traits.在数量性状的基因定位研究中,使用边际上位性检验检测上位性。
PLoS Genet. 2017 Jul 26;13(7):e1006869. doi: 10.1371/journal.pgen.1006869. eCollection 2017 Jul.

引用本文的文献

1
Association of Epistatic Effects of lncRNA GAS5, miR-146a, IRAK-1, and miR-155 Genetic Variants with Multiple Sclerosis Risk and Severity.lncRNA GAS5、miR-146a、IRAK-1和miR-155基因变异的上位性效应与多发性硬化症风险及严重程度的关联
Mol Neurobiol. 2025 Apr 15. doi: 10.1007/s12035-025-04876-8.
2
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.多发性硬化症的多基因性质:基因变异、免疫调节及与环境的关联
Endocr Metab Immune Disord Drug Targets. 2024 Dec 31. doi: 10.2174/0118715303325979241206115417.
3
Heterogeneous network approaches to protein pathway prediction.

本文引用的文献

1
GLI1: A Therapeutic Target for Cancer.GLI1:癌症的一个治疗靶点。
Front Oncol. 2021 May 25;11:673154. doi: 10.3389/fonc.2021.673154. eCollection 2021.
2
Novel methods for epistasis detection in genome-wide association studies.全基因组关联研究中上位性检测的新方法。
PLoS One. 2020 Nov 30;15(11):e0242927. doi: 10.1371/journal.pone.0242927. eCollection 2020.
3
Pathogen Evasion of Chemokine Response Through Suppression of CXCL10.病原体通过抑制 CXCL10 来逃避趋化因子反应。
用于蛋白质通路预测的异构网络方法。
Comput Struct Biotechnol J. 2024 Jun 27;23:2727-2739. doi: 10.1016/j.csbj.2024.06.022. eCollection 2024 Dec.
4
MR-GGI: accurate inference of gene-gene interactions using Mendelian randomization.MR-GGI:利用孟德尔随机化准确推断基因-基因相互作用。
BMC Bioinformatics. 2024 May 15;25(1):192. doi: 10.1186/s12859-024-05808-4.
5
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.多发性硬化症的遗传风险在草原牧民群体中升高。
Nature. 2024 Jan;625(7994):321-328. doi: 10.1038/s41586-023-06618-z. Epub 2024 Jan 10.
6
Subtypes of relapsing-remitting multiple sclerosis identified by network analysis.通过网络分析确定的复发缓解型多发性硬化症亚型。
Front Digit Health. 2023 Jan 11;4:1063264. doi: 10.3389/fdgth.2022.1063264. eCollection 2022.
Front Cell Infect Microbiol. 2019 Aug 7;9:280. doi: 10.3389/fcimb.2019.00280. eCollection 2019.
4
Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7.髓鞘形成雪旺细胞在 E3 连接酶组分 Fbxw7 缺失的情况下包裹多个轴突。
Nat Commun. 2019 Jul 5;10(1):2976. doi: 10.1038/s41467-019-10881-y.
5
Open Targets Platform: new developments and updates two years on.开放靶点平台:两年的新发展和更新。
Nucleic Acids Res. 2019 Jan 8;47(D1):D1056-D1065. doi: 10.1093/nar/gky1133.
6
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.阅读孟德尔随机化研究:临床医生指南、词汇表和清单。
BMJ. 2018 Jul 12;362:k601. doi: 10.1136/bmj.k601.
7
Genome-wide association studies of multiple sclerosis.多发性硬化症的全基因组关联研究。
Clin Transl Immunology. 2018 May 31;7(6):e1018. doi: 10.1002/cti2.1018. eCollection 2018.
8
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.NI-0801,一种抗趋化因子(C-X-C基序)配体10抗体,用于治疗原发性胆汁性胆管炎且对熊去氧胆酸反应不完全的患者。
Hepatol Commun. 2018 Mar 23;2(5):492-503. doi: 10.1002/hep4.1170. eCollection 2018 May.
9
NF-κB in the crosshairs: Rethinking an old riddle.NF-κB 成为焦点:重新思考一个古老的谜题。
Int J Biochem Cell Biol. 2018 Feb;95:108-112. doi: 10.1016/j.biocel.2017.12.020. Epub 2017 Dec 23.
10
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.CXCL9、CXCL10、CXCL11/CXCR3免疫激活轴——新型癌症治疗的靶点
Cancer Treat Rev. 2018 Feb;63:40-47. doi: 10.1016/j.ctrv.2017.11.007. Epub 2017 Nov 26.